 |
市场调查报告书
商品编码
1477276
预防疫苗市场，按疫苗类型，按疾病类型，按配销通路，按地理Preventive Vaccines Market, By Vaccine Type, By Disease Type, By Distribution Channel, By Geography |
||||||
预计2024年全球预防性疫苗市值为504.1亿美元，预计2031年将达到963.5亿美元，2024年至2031年年复合成长率（CAGR）为9.7%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年： | 2023年 | 2024 年市场规模： | 504.1 亿美元 |
| 历史数据： | 2019年至2023年 | 预测期： | 2024年至2031年 |
| 预测 2024 年至 2031 年复合年增长率： | 9.70% | 2031 年价值预测： | 963.5 亿美元 |
由于世界各地各种传染病负担不断增加，全球预防性疫苗市场正经历一段增长期。预防性疫苗是增强对某些疾病的免疫力并有助于预防未来感染的生物製剂。多年来，疫苗学的各种进步促进了免疫接种的发展，以保护个人免受危及生命的疾病的侵害。此外，免疫意识的增强和疫苗技术的不断创新也推动了对预防性疫苗的需求。一些国家政府实施了国家免疫规划，以提高疫苗接种覆盖率。公共和私人来源的传染病医疗保健支出的增加也有助于预防性疫苗市场的扩大。然而，新疫苗开发的高昂研发成本以及低收入国家缺乏认识是阻碍市场成长的一些因素。
市场动态：
全球预防性疫苗市场的成长主要是由目标传染病的盛行率不断上升所推动的。新兴国家与细菌和病毒感染相关的大量未满足的医疗需求正在推动对免疫和疫苗接种计划的需求。各国政府和非营利组织为加强国家免疫规划所采取的各种措施增加了预防性疫苗的使用。例如，印度国家免疫计划旨在免费提供针对 12 种危及生命的疾病的疫苗。疫苗产品开发的技术进步提高了免疫原性和稳定性，释放了新的成长机会。然而，新疫苗研发、测试、临床试验和生产相关的高成本预计将在预测期内一定程度上抑制市场扩张。人们日益关注开发联合疫苗以降低疫苗接种成本，这在未来几年提供了利润丰厚的机会。
研究的主要特点：
- 该报告对全球预防性疫苗市场进行了深入分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
- 它阐明了不同细分市场的潜在收入机会，并解释了该市场有吸引力的投资主张矩阵。
- 这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
- 它根据以下参数描述了全球预防性疫苗市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
- 该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球预防性疫苗市场迎合了该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和金融分析师。
- 利害关係人可以透过用于分析全球预防性疫苗市场的各种策略矩阵轻鬆做出决策。
目录
第一章：研究目标与假设
- 研究目标
- 假设
- 缩写
第 2 章：市场范围
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map (COM)
第 3 章：市场动态、法规与趋势分析
- 市场动态
- 司机
- 限制
- 机会
- 影响分析
- 市场走向
- 主要进展
- 监管场景
- 管道分析
- 流行病学
- 定价和品牌分析
- 製造商收入
- 收购和合作场景
- 产品发布/批准
- 资金和投资
- PEST分析
- 波特的分析
第 4 章：全球预防疫苗市场 - 冠状病毒 (COVID-19) 大流行的影响
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第 5 章：全球预防疫苗市场，依疫苗类型，2019 - 2031 年（十亿美元）
- 概述
- 活疫苗/减毒疫苗
- 灭活疫苗
- 亚单位疫苗
- 类毒素疫苗
- 其他的
第 6 章：全球预防疫苗市场，依疾病类型，2019 - 2031 年（十亿美元）
- 概述
- 肺炎球菌
- 小儿麻痹病毒
- 肝炎
- 流感
- 麻疹
- 风疹
- 其他的
第 7 章：全球预防疫苗市场，按配销通路划分，2019 - 2031 年（十亿美元）
- 概述
- 民众
- 私人的
第 8 章：全球预防疫苗市场，按地区划分，2019 - 2031 年（十亿美元）
- 介绍
- 北美洲
- 我们
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
- 欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 欧洲其他地区
- 亚太地区
- 中国
- 印度
- 日本
- 东协
- 澳洲
- 韩国
- 亚太地区其他地区
- 中东
- 海湾合作委员会
- 以色列
- 中东其他地区
- 非洲
- 北非
- 中非
- 南非
第 9 章：竞争格局
- 公司简介
- Sanofi
- Pfizer Inc.
- Merck & Co. Inc.
- GSK plc.
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Daiichi Sankyo Co. Ltd.
- Emergent BioSolutions Inc.
- Novavax Inc.
- Zydus Group
- Moderna, Inc.
- Sinopharm Group Co. Ltd.
- Valneva SE
- Serum Institute of India Pvt. Ltd.
- Johnson & Johnson Services, Inc.
- Bharat Biotech
- Regeneron Pharmaceuticals Inc.
第 10 章：分析师观点
- 命运之轮
- 分析师观点
- 连贯的机会图
第 11 章：参考文献与研究方法
- 参考
- 研究方法论
The global preventive vaccines market is estimated to be valued at USD 50.41 Bn in 2024 and is expected to reach USD 96.35 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.7% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 50.41 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 9.70% | 2031 Value Projection: | US$ 96.35 Bn |
The global preventive vaccines market is witnessing a period of growth owing to the rising burden of various infectious diseases across the world. Preventive vaccines are biological preparations that enhance immunity against certain diseases and help prevent future infections. Over the years, various advancements in vaccinology have enabled the development of immunization to safeguard individuals from life-threatening illnesses. Moreover, growing awareness regarding immunization and continuous innovation in vaccine technologies are fueling the demand for preventive vaccines. Governments of several countries have implemented national immunization programs to promote vaccination coverage. Rising healthcare expenditures on communicable diseases from public and private sources are also contributing to the expansion of the preventive vaccines market. However, high research and development costs involved in new vaccine development and lack of awareness in low-income nations are some of the factors hindering the market growth.
Market Dynamics:
The global preventive vaccines market growth is primarily driven by the increasing prevalence of target infectious diseases. Significant unmet medical needs associated with bacterial and viral infections across the emerging nations are driving the demand for immunization and vaccination programs. Various initiatives taken by governments and non-profit organizations to strengthen national immunization programs have augmented the uptake of preventive vaccines. For instance, the National Immunization Program of India aims to provide vaccines against 12 life-threatening diseases free of cost. Technological advancements in vaccine product development with improved immunogenicity and stability have unlocked new growth opportunities. However, high costs associated with new vaccine R&D, testing, clinical trials, and production are expected to restrain the market expansion to some extent during the forecast period. Rising focus on development of combination vaccines to lower vaccination costs offers lucrative opportunities in the forthcoming years.
Key Features of the Study:
- This report provides in-depth analysis of the global preventive vaccines market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global preventive vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study Sanofi, Pfizer Inc., Merck & Co. Inc., GSK plc., Takeda Pharmaceutical Company Limited, AstraZeneca, Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., Novavax Inc., Zydus Group, Moderna, Inc., Sinopharm Group Co. Ltd., Valneva SE, Serum Institute of India Pvt. Ltd., Johnson & Johnson Services, Inc., Bharat Biotech, and Regeneron Pharmaceuticals Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global preventive vaccines market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preventive vaccines market.
Detailed Segmentation-
- By Vaccine Type:
- Live/Attenuated Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- Others
- By Disease Type:
- Pneumococcal
- Poliovirus
- Hepatitis
- Influenza
- Measles
- Rubella
- Others
- By Distribution Channel:
- Public
- Private
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Sanofi
- Pfizer Inc.
- Merck & Co. Inc.
- GSK plc.
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Daiichi Sankyo Co. Ltd.
- Emergent BioSolutions Inc.
- Novavax Inc.
- Zydus Group
- Moderna, Inc.
- Sinopharm Group Co. Ltd.
- Valneva SE
- Serum Institute of India Pvt. Ltd.
- Johnson & Johnson Services, Inc.
- Bharat Biotech
- Regeneron Pharmaceuticals Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Disease Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Pipeline Analysis
- Epidemiology
- Pricing and Brand Analysis
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Preventive Vaccines Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
5. Global Preventive Vaccines Market, By Vaccine Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Live/Attenuated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Inactivated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Subunit Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Toxoid Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Preventive Vaccines Market, By Disease Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Pneumococcal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Poliovirus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hepatitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Influenza
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Measles
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Rubella
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Preventive Vaccines Market, By Distribution Channel, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Public
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Preventive Vaccines Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Merck & Co. Inc.
- GSK plc.
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Daiichi Sankyo Co. Ltd.
- Emergent BioSolutions Inc.
- Novavax Inc.
- Zydus Group
- Moderna, Inc.
- Sinopharm Group Co. Ltd.
- Valneva SE
- Serum Institute of India Pvt. Ltd.
- Johnson & Johnson Services, Inc.
- Bharat Biotech
- Regeneron Pharmaceuticals Inc.
10. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
![狂犬病疫苗市场 - 按产品类型 [婴儿仓鼠肾 (BHK)、Vero 细胞狂犬病疫苗]、类型（人用、兽用）、应用（暴露前预防、暴露后预防）、配销通路、全球预测（2024 年- 2032 年）](/sample/img/cover/42/1535700.png)
狂犬病疫苗市场 - 按产品类型 [婴儿仓鼠肾 (BHK)、Vero 细胞狂犬病疫苗]、类型（人用、兽用）、应用（暴露前预防、暴露后预防）、配销通路、全球预测（2024 年- 2032 年）
狂犬病疫苗市场，按产品类型、应用、预防类型、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测
人类狂犬病疫苗市场：细胞株类型、给药途径、应用、配销通路- 全球预测 2024-2030
狂犬病疫苗市场：按产品类型、按预防类型、按应用、按最终用户：2023-2032 年全球机会分析和产业预测
狂犬病疫苗市场报告：2030 年趋势、预测与竞争分析
百日咳疫苗市场报告：2030 年趋势、预测与竞争分析
灭活脊髓灰质炎·狂犬病(恐水症)疫苗市场:疫苗，各灭活方法，各年龄层，各流通管道，各地区- 市场规模，占有率，展望，机会分析，2023年～2030年
2023-2030 年全球预防性疫苗市场